全文获取类型
收费全文 | 229882篇 |
免费 | 4497篇 |
国内免费 | 115篇 |
专业分类
耳鼻咽喉 | 1664篇 |
儿科学 | 8880篇 |
妇产科学 | 4508篇 |
基础医学 | 23384篇 |
口腔科学 | 2087篇 |
临床医学 | 20900篇 |
内科学 | 40105篇 |
皮肤病学 | 1423篇 |
神经病学 | 21576篇 |
特种医学 | 9924篇 |
外科学 | 33340篇 |
综合类 | 2902篇 |
一般理论 | 109篇 |
预防医学 | 25582篇 |
眼科学 | 3496篇 |
药学 | 13046篇 |
中国医学 | 691篇 |
肿瘤学 | 20877篇 |
出版年
2023年 | 309篇 |
2022年 | 489篇 |
2021年 | 1079篇 |
2020年 | 743篇 |
2019年 | 1135篇 |
2018年 | 23016篇 |
2017年 | 18219篇 |
2016年 | 20454篇 |
2015年 | 2149篇 |
2014年 | 2523篇 |
2013年 | 3506篇 |
2012年 | 10870篇 |
2011年 | 25074篇 |
2010年 | 21002篇 |
2009年 | 13545篇 |
2008年 | 23148篇 |
2007年 | 25574篇 |
2006年 | 4442篇 |
2005年 | 6184篇 |
2004年 | 7176篇 |
2003年 | 7911篇 |
2002年 | 5779篇 |
2001年 | 744篇 |
2000年 | 765篇 |
1999年 | 644篇 |
1998年 | 879篇 |
1997年 | 805篇 |
1996年 | 569篇 |
1995年 | 575篇 |
1994年 | 521篇 |
1993年 | 397篇 |
1992年 | 291篇 |
1991年 | 306篇 |
1990年 | 311篇 |
1989年 | 286篇 |
1988年 | 247篇 |
1987年 | 213篇 |
1986年 | 199篇 |
1985年 | 203篇 |
1984年 | 215篇 |
1983年 | 197篇 |
1982年 | 245篇 |
1981年 | 212篇 |
1980年 | 199篇 |
1979年 | 106篇 |
1978年 | 134篇 |
1977年 | 59篇 |
1976年 | 71篇 |
1974年 | 91篇 |
1938年 | 60篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Peter Angelos 《World journal of surgery》2009,33(4):609-611
52.
Kentaroh Miyoshi Minoru Naito Tsuyoshi Ueno Shinji Hato Hideo Ino 《General thoracic and cardiovascular surgery》2009,57(11):629-632
A benign esophageal leiomyoma with abnormally increased fluorine-18-fluorodeoxyglucose uptake on positron emission tomography
(PET) was resected thoracoscopically. The tumor, of which the maximum standardized uptake value of the lesion was 4.7, was
well defined and 38 mm in diameter. Neither mitotic activity nor degeneration was found histologically; and immunoreactivity
for CD34, CD117, MIB-1, and glucose transporter-1 was negative immunohistochemically. A diagnosis of gastrointestinal stromal
tumor was ruled out by an oncogenic kinase gene mutation study. This case cautions against PET-dependent evaluation for malignant
potential of esophageal submucosal tumors. 相似文献
53.
54.
55.
Emmanuel J Favaloro Roslyn Bonar Elizabeth Duncan Susan Rodgers Katherine Marsden 《Blood coagulation & fibrinolysis》2007,18(5):441-448
The PFA-100 is a relatively new laboratory instrument, first described in 1995. There have since been numerous studies assessing its utility as a screening tool for platelet dysfunction and/or von Willebrand's disease (VWD). The PFA-100 displays variable sensitivity to different types of platelet disorders, as well as to antiplatelet medication (e.g. aspirin), with similar caveats for monitoring of primary haemostasis-promoting therapies in platelet dysfunction. There is therefore considerable uncertainty regarding its utility within this context, and we have accordingly performed an audit of usage among participants of the Royal College of Pathologists of Australasia Quality Assurance Program. Of 105 laboratories surveyed, 40 responded that they performed platelet function testing, with 26 (65%) further indicating they utilized the PFA-100. We report a wide variety of laboratory usage among these users, including numbers of tests performed [annual median (range) = 270 (15-6000)], sources of requests (clinical sources and localities), testing criteria and follow-up action. Most tests were completed within 4 h of collection, as recommended by the manufacturer, and most tests were performed as a replacement, or as a preliminary screen of platelet function (i.e. classical aggregation). Most abnormal findings, however, were attributed to antiplatelet medication such as aspirin. 相似文献
56.
57.
Simon Bell Andrew J McLachlan Parisa Aslani Paula Whitehead Timothy F Chen 《Australia and New Zealand Health Policy》2005,2(1):29
The objective of this systematic review was to evaluate the impact of pharmacist delivered community-based services to optimise the use of medications for mental illness. Twenty-two controlled (randomised and non-randomised) studies of pharmacists' interventions in community and residential aged care settings identified in international scientific literature were included for review. Papers were assessed for study design, service recipient, country of origin, intervention type, number of participating pharmacists, methodological quality and outcome measurement. Three studies showed that pharmacists' medication counselling and treatment monitoring can improve adherence to antidepressant medications among those commencing treatment when calculated using an intention-to-treat analysis. Four trials demonstrated that pharmacist conducted medication reviews may reduce the number of potentially inappropriate medications prescribed to those at high risk of medication misadventure. The results of this review provide some evidence that pharmacists can contribute to optimising the use of medications for mental illness in the community setting. However, more well designed studies are needed to assess the impact of pharmacists as members of community mental health teams and as providers of comprehensive medicines information to people with schizophrenia and bipolar disorder 相似文献
58.
59.
Statutory reimbursement agencies as well as private insurers throughout member states of the Organization for Economic Cooperation and Development (OECD) reimburse the cost of medicines on the basis of criteria that include robust clinical evidence, budget impact analysis, and incremental cost effectiveness. The Centers for Medicare and Medicaid Services (CMS) in the US are no exception to this rule and are, in principle, seeking to maximize benefit for their Medicare enrollees, whilst ensuring reasonable drug outlays for the small number of drugs that they reimburse. This paper provides a retrospective analysis of the way two functionally equivalent drugs are treated for reimbursement purposes by the CMS; the period under consideration was 2001–3. The two drugs, epoetin-α and darbepoetin-α, are used for the treatment of anemia in renal failure and in patients receiving chemotherapy. By reviewing the publicly available pharmacological and clinical data of epoetin-α and darbepoetin-α, the paper confirms the two drugs’ functional equivalence, despite their structural differences. The implications of dose conversion ratios and costs to Medicare are subsequently explored. It is argued that the issue of dose equivalence between epoetin-α and darbepoetin-α has significant implications for patients, practitioners, and payors. A payor’s perspective is adopted in this respect, whereby clinical evidence and pricing data are used simultaneously. Based on the clinical evidence, a dose conversion ratio for epoetin-α:darbepoetin-α is established, which achieves a comparable clinical effect for the two drugs and this is set to be <254IU:1μg. The incremental costs to Medicare are calculated subsequently. The Average Wholesale Price and the Outpatient Prospective Payment System rule that Medicare uses to reimburse providers are used and suggest that treatment of cancer patients with chemotherapy-related anemia with epoetin-α would save Medicare an estimated $US600 million each year. Patients would also benefit significantly in terms of lower co-payments for epoetin-α. The evidence is supportive of the decision made by the CMS to reimburse the two drugs at the rate reflecting the achievement of comparable clinical effects and therefore reducing the pass-through payments for darbepoetin-α to zero for the 2002–3 fiscal year. 相似文献
60.
BACKGROUND: Patients with multi-handicaps present clinical challenges and are underserved. Central nervous system dysfunction and ocular disorders with this population are prevalent and well-documented. However, vision care outcomes data are limited and specific visual function recommendations to caregivers are rarely cited. METHODS: The charts of 110 multiply handicapped adults residing in 22 group homes in Wayne County. Michigan were retrospectively studied to identify ocular profiles and predictors of visual function. RESULTS: Sixty-five percent of the subjects were male and 80% were ages 26 to 55 years. There was no expressive language in 41%, and 37% were non-ambulatory. The median visual impairment level was moderate in both eyes (based on WHO). Significant associations between visual impairment level and subpopulations (such as seizure disorder, mental retardation without specific etiology, cerebral palsy, and Down syndrome) were identified. Successful spectacle wear statistically increased with higher refractive errors. Associations between cataract, nystagmus, and strabismus with particular subpopulations were significant (all P values < 0.0182). CONCLUSIONS: Clinicians who evaluate patients with multi-handicaps have few known predictors of treatment success. This study indicates that useful predictors of visual function can be made from refractive error, systemic conditions, and ocular diagnoses. No significant relationship was found with cognitive level and either vision impairment or spectacle use. The authors attribute successful implementation of recommendations to communication with group home caregivers. 相似文献